Canada Generic Drug Market 2016 - Drivers, Sales Trends, Prescription Trends, Market Structure & Competitive Landscape - Research and Markets

News provided by

Jun 13, 2016, 04:10 ET

DUBLIN, June 13, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook" report to their offering.

Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada.

This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Canada represents the world's ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalyzed by a number of factors.

Key Topics Covered:

1 Research Methodology and Market Definitions

2 Report Summary

3 Canada Generic Drug Market - Introduction

4 Why is the Generic Drug Market so Lucrative in Canada

5 Global Generic Drug Market

6 Canada Generic Drug Market

7 Canada Generic Drug Market- Competitive Landscape

8 Canada Generic Drug Market - Value Chain Analysis

9 Canada Generic Drug Market - Regulatory Framework

10 Canada Generic Drug Market: Key Success Factors

11 Canada Generic Drug Market: Road Blocks

12 Requirements for Setting Up a Generic Drug Manufacturing Plant

13 Canada Generic Drug Market - Key Company Profiles
13.1 Teva Pharmaceutical Ltd.
13.2 Apotex Inc.
13.3 Sandoz Canada
13.4 Actavis
13.5 Mylan
13.6 Pharmascience Inc.
13.7 Taro Pharmaceuticals
13.8 Novartis
13.9 Ranbaxy Pharmaceuticals Canada
13.10 Hospira

For more information visit http://www.researchandmarkets.com/research/nfx66d/canada_generic

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets